Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study.

Publication Year: 2021

DOI:
10.1007/s00403-021-02243-w

PMCID:
PMC9232418

PMID:
34100126

Journal Information

Full Title: Arch Dermatol Res

Abbreviation: Arch Dermatol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestProf. Campanati A. speaker or board member for Abbvie, Galderma, Celgene, Leo-pharma, Eli Lilly, Merck Sharp and Dohme, Novartis, Pfizer, UCB. Prof. Amerio P. speaker and advisor for Abbvie, Eli Lilly, Galderma, Novartis, Sanofi-Genzyme, Janssen, Pfizer, Sandoz. Prof. Parodi A. speaker and advisor for Novartis, Almirall, Sanofi, Celgene, Amgen, Abbvie, Leo pharma, Lilly, Janssen, Pfizer, Galderma, Boehringer. Prof. Cannavò SP speaker or board member for Abbvie, Eli-Lilly, Janssen-Cilag, Leo Pharma, Novartis, Sanofi-Genzyme. Prof. Fargnoli MC speaker or board member for Almirall, Abbvie, Galderma, Leo Pharma, Mylan, Medac Pharma, Celgene, Pierre Fabre, UCB, Eli Lilly, Pfizer, Janssen, Novartis, Sanofi-Genzyme, Roche, Sunpharma, MSD. Prof. Potenza C, speaker and board member for, Almirall, Amgen, Abbvie, Celgene Leo pharma, Eli-Lilly, Janssen, Pfizer, Novartis, Sanofi- Genzyme. Prof. Offidani A, speaker or board member for Abbvie, Galderma, Celgene, Janssen, Leo-pharma, Eli Lilly, Merck Sharp and Dohme, Novartis, Pfizer, UCB. Conflict of interest Prof. Campanati A. speaker or board member for Abbvie, Galderma, Celgene, Leo-pharma, Eli Lilly, Merck Sharp and Dohme, Novartis, Pfizer, UCB. Prof. Amerio P. speaker and advisor for Abbvie, Eli Lilly, Galderma, Novartis, Sanofi-Genzyme, Janssen, Pfizer, Sandoz. Prof. Parodi A. speaker and advisor for Novartis, Almirall, Sanofi, Celgene, Amgen, Abbvie, Leo pharma, Lilly, Janssen, Pfizer, Galderma, Boehringer. Prof. Cannavò SP speaker or board member for Abbvie, Eli-Lilly, Janssen-Cilag, Leo Pharma, Novartis, Sanofi-Genzyme. Prof. Fargnoli MC speaker or board member for Almirall, Abbvie, Galderma, Leo Pharma, Mylan, Medac Pharma, Celgene, Pierre Fabre, UCB, Eli Lilly, Pfizer, Janssen, Novartis, Sanofi-Genzyme, Roche, Sunpharma, MSD. Prof. Potenza C, speaker and board member for, Almirall, Amgen, Abbvie, Celgene Leo pharma, Eli-Lilly, Janssen, Pfizer, Novartis, Sanofi- Genzyme. Prof. Offidani A, speaker or board member for Abbvie, Galderma, Celgene, Janssen, Leo-pharma, Eli Lilly, Merck Sharp and Dohme, Novartis, Pfizer, UCB."

Evidence found in paper:

"Funding Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025